SCHEMBL16627140

SCHEMBL16627140

COc1ccc(C(OCc2ccc(Cl)nc2)(c2ccccc2)c2ccc(C)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
ALDH1A1 P00352 2/20 0.41
TERT O14746 2/20 0.40
LMNA P02545 2/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
POLB P06746 1/20 0.39
NLRP3 Q96P20 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 2/20 0.37
NPBWR1 P48145 1/20 0.37
MCHR1 Q99705 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MAOB P27338 1/20 0.36
HCRTR2 O43614 1/20 0.36
LTA4H P09960 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16624686 0.95 NPC1 (0.44) KIF11NPC1RAB9AALDH1A1TERT
SCHEMBL16624800 0.89 MEN1 (0.42) NPC1RAB9AALDH1A1TERTLMNA
SCHEMBL19020521 0.85 KIF11 (0.50) KIF11LMNAHTTSMN1; SMN2MAOB
SCHEMBL16627145 0.84 LTA4H (0.41) KIF11NPC1RAB9ALMNAHTT
SCHEMBL16628094 0.78 CYP11B1 (0.45) NPC1RAB9AALDH1A1LMNASMN1; SMN2
SCHEMBL28241152 0.77 LTA4H (0.52) KIF11NPC1RAB9AMAOBLTA4H
SCHEMBL16624847 0.76 CASP3 (0.50) KIF11NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL16627149 0.75 GAA (0.48) HTTSMN1; SMN2MEN1KMT2ALTA4H
Hydrochloric Acid SCHEMBL30186367 0.75 LTA4H (0.50) KIF11NPC1RAB9AMAOBLTA4H
SCHEMBL17954315 0.75 CASP3 (0.46) NPC1RAB9ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015051044-A2 NOVEL FORMATS FOR ORGANIC COMPOUNDS FOR USE IN RNA INTERFERENCE NOVARTIS AG (CH) 2015-04-09 WO disclosed